Learn More
Genscript Corporation SARS-CoV-2 Neutralizing Antibo
Supplier: Genscript Corporation A02088100

The product is specific for SARS-CoV-2 Spike Protein S1 subunit and its RBD domain The product can recognize and neutralize Wild-Type SARS-CoV-2 and Variants of Concern (VOC) including Alpha Beta Delta and Omicron Reactivity with Gamma variant has not been tested
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.